nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000702	0.000702	CcSEcCtD
Meropenem—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.0007	0.0007	CcSEcCtD
Meropenem—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000698	0.000698	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000697	0.000697	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000691	0.000691	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000691	0.000691	CcSEcCtD
Meropenem—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000686	0.000686	CcSEcCtD
Meropenem—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000685	0.000685	CcSEcCtD
Meropenem—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000685	0.000685	CcSEcCtD
Meropenem—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000681	0.000681	CcSEcCtD
Meropenem—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000681	0.000681	CcSEcCtD
Meropenem—Nausea—Topotecan—peripheral nervous system neoplasm	0.000681	0.000681	CcSEcCtD
Meropenem—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000679	0.000679	CcSEcCtD
Meropenem—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000678	0.000678	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000677	0.000677	CcSEcCtD
Meropenem—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000675	0.000675	CcSEcCtD
Meropenem—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000675	0.000675	CcSEcCtD
Meropenem—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000675	0.000675	CcSEcCtD
Meropenem—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000673	0.000673	CcSEcCtD
Meropenem—Infection—Etoposide—peripheral nervous system neoplasm	0.000668	0.000668	CcSEcCtD
Meropenem—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000667	0.000667	CcSEcCtD
Meropenem—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000667	0.000667	CcSEcCtD
Meropenem—Nausea—Melphalan—peripheral nervous system neoplasm	0.000667	0.000667	CcSEcCtD
Meropenem—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000665	0.000665	CcSEcCtD
Meropenem—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000663	0.000663	CcSEcCtD
Meropenem—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000659	0.000659	CcSEcCtD
Meropenem—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000659	0.000659	CcSEcCtD
Meropenem—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000656	0.000656	CcSEcCtD
Meropenem—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000656	0.000656	CcSEcCtD
Meropenem—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000656	0.000656	CcSEcCtD
Meropenem—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000656	0.000656	CcSEcCtD
Meropenem—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000655	0.000655	CcSEcCtD
Meropenem—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000653	0.000653	CcSEcCtD
Meropenem—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00065	0.00065	CcSEcCtD
Meropenem—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000646	0.000646	CcSEcCtD
Meropenem—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000641	0.000641	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000639	0.000639	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000639	0.000639	CcSEcCtD
Meropenem—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000638	0.000638	CcSEcCtD
Meropenem—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000636	0.000636	CcSEcCtD
Meropenem—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000635	0.000635	CcSEcCtD
Meropenem—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000634	0.000634	CcSEcCtD
Meropenem—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000628	0.000628	CcSEcCtD
Meropenem—Pain—Cisplatin—peripheral nervous system neoplasm	0.000628	0.000628	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000626	0.000626	CcSEcCtD
Meropenem—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.00062	0.00062	CcSEcCtD
Meropenem—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.00062	0.00062	CcSEcCtD
Meropenem—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000618	0.000618	CcSEcCtD
Meropenem—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000618	0.000618	CcSEcCtD
Meropenem—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000613	0.000613	CcSEcCtD
Meropenem—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000612	0.000612	CcSEcCtD
Meropenem—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00061	0.00061	CcSEcCtD
Meropenem—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000607	0.000607	CcSEcCtD
Meropenem—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000605	0.000605	CcSEcCtD
Meropenem—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000604	0.000604	CcSEcCtD
Meropenem—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.0006	0.0006	CcSEcCtD
Meropenem—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000598	0.000598	CcSEcCtD
Meropenem—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000596	0.000596	CcSEcCtD
Meropenem—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000595	0.000595	CcSEcCtD
Meropenem—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000591	0.000591	CcSEcCtD
Meropenem—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000591	0.000591	CcSEcCtD
Meropenem—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000591	0.000591	CcSEcCtD
Meropenem—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00059	0.00059	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000586	0.000586	CcSEcCtD
Meropenem—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000586	0.000586	CcSEcCtD
Meropenem—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000585	0.000585	CcSEcCtD
Meropenem—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000581	0.000581	CcSEcCtD
Meropenem—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000581	0.000581	CcSEcCtD
Meropenem—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00058	0.00058	CcSEcCtD
Meropenem—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000579	0.000579	CcSEcCtD
Meropenem—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000576	0.000576	CcSEcCtD
Meropenem—Pain—Etoposide—peripheral nervous system neoplasm	0.000575	0.000575	CcSEcCtD
Meropenem—Constipation—Etoposide—peripheral nervous system neoplasm	0.000575	0.000575	CcSEcCtD
Meropenem—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000574	0.000574	CcSEcCtD
Meropenem—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000574	0.000574	CcSEcCtD
Meropenem—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00057	0.00057	CcSEcCtD
Meropenem—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000568	0.000568	CcSEcCtD
Meropenem—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000567	0.000567	CcSEcCtD
Meropenem—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000559	0.000559	CcSEcCtD
Meropenem—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000558	0.000558	CcSEcCtD
Meropenem—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000554	0.000554	CcSEcCtD
Meropenem—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000552	0.000552	CcSEcCtD
Meropenem—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000552	0.000552	CcSEcCtD
Meropenem—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.00055	0.00055	CcSEcCtD
Meropenem—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00055	0.00055	CcSEcCtD
Meropenem—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000549	0.000549	CcSEcCtD
Meropenem—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000548	0.000548	CcSEcCtD
Meropenem—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000547	0.000547	CcSEcCtD
Meropenem—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000547	0.000547	CcSEcCtD
Meropenem—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000543	0.000543	CcSEcCtD
Meropenem—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000543	0.000543	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000542	0.000542	CcSEcCtD
Meropenem—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000541	0.000541	CcSEcCtD
Meropenem—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00054	0.00054	CcSEcCtD
Meropenem—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00054	0.00054	CcSEcCtD
Meropenem—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000538	0.000538	CcSEcCtD
Meropenem—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000536	0.000536	CcSEcCtD
Meropenem—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000534	0.000534	CcSEcCtD
Meropenem—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000533	0.000533	CcSEcCtD
Meropenem—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000533	0.000533	CcSEcCtD
Meropenem—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000532	0.000532	CcSEcCtD
Meropenem—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000532	0.000532	CcSEcCtD
Meropenem—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000531	0.000531	CcSEcCtD
Meropenem—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000531	0.000531	CcSEcCtD
Meropenem—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000528	0.000528	CcSEcCtD
Meropenem—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000527	0.000527	CcSEcCtD
Meropenem—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000527	0.000527	CcSEcCtD
Meropenem—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000524	0.000524	CcSEcCtD
Meropenem—Rash—Vincristine—peripheral nervous system neoplasm	0.000524	0.000524	CcSEcCtD
Meropenem—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000523	0.000523	CcSEcCtD
Meropenem—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000523	0.000523	CcSEcCtD
Meropenem—Headache—Vincristine—peripheral nervous system neoplasm	0.00052	0.00052	CcSEcCtD
Meropenem—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000517	0.000517	CcSEcCtD
Meropenem—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000516	0.000516	CcSEcCtD
Meropenem—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000512	0.000512	CcSEcCtD
Meropenem—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00051	0.00051	CcSEcCtD
Meropenem—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000502	0.000502	CcSEcCtD
Meropenem—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000502	CcSEcCtD
Meropenem—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.0005	0.0005	CcSEcCtD
Meropenem—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000496	0.000496	CcSEcCtD
Meropenem—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000494	0.000494	CcSEcCtD
Meropenem—Nausea—Vincristine—peripheral nervous system neoplasm	0.000493	0.000493	CcSEcCtD
Meropenem—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000491	0.000491	CcSEcCtD
Meropenem—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000491	0.000491	CcSEcCtD
Meropenem—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000487	0.000487	CcSEcCtD
Meropenem—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000484	0.000484	CcSEcCtD
Meropenem—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000483	0.000483	CcSEcCtD
Meropenem—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000479	0.000479	CcSEcCtD
Meropenem—Chills—Epirubicin—peripheral nervous system neoplasm	0.000476	0.000476	CcSEcCtD
Meropenem—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000476	0.000476	CcSEcCtD
Meropenem—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000467	0.000467	CcSEcCtD
Meropenem—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000464	CcSEcCtD
Meropenem—Rash—Cisplatin—peripheral nervous system neoplasm	0.000463	0.000463	CcSEcCtD
Meropenem—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000462	0.000462	CcSEcCtD
Meropenem—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000462	0.000462	CcSEcCtD
Meropenem—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00046	0.00046	CcSEcCtD
Meropenem—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000455	0.000455	CcSEcCtD
Meropenem—Tension—Epirubicin—peripheral nervous system neoplasm	0.000453	0.000453	CcSEcCtD
Meropenem—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000452	0.000452	CcSEcCtD
Meropenem—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000449	0.000449	CcSEcCtD
Meropenem—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000447	0.000447	CcSEcCtD
Meropenem—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000445	0.000445	CcSEcCtD
Meropenem—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000444	0.000444	CcSEcCtD
Meropenem—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000441	CcSEcCtD
Meropenem—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Meropenem—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000428	0.000428	CcSEcCtD
Meropenem—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.000427	CcSEcCtD
Meropenem—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000427	0.000427	CcSEcCtD
Meropenem—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000425	0.000425	CcSEcCtD
Meropenem—Rash—Etoposide—peripheral nervous system neoplasm	0.000424	0.000424	CcSEcCtD
Meropenem—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000424	0.000424	CcSEcCtD
Meropenem—Headache—Etoposide—peripheral nervous system neoplasm	0.000421	0.000421	CcSEcCtD
Meropenem—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.000421	CcSEcCtD
Meropenem—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000419	0.000419	CcSEcCtD
Meropenem—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000419	0.000419	CcSEcCtD
Meropenem—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000417	0.000417	CcSEcCtD
Meropenem—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000415	CcSEcCtD
Meropenem—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000414	CcSEcCtD
Meropenem—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000414	CcSEcCtD
Meropenem—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.000413	CcSEcCtD
Meropenem—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000406	0.000406	CcSEcCtD
Meropenem—Cough—Epirubicin—peripheral nervous system neoplasm	0.000403	0.000403	CcSEcCtD
Meropenem—Nausea—Etoposide—peripheral nervous system neoplasm	0.0004	0.0004	CcSEcCtD
Meropenem—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000399	CcSEcCtD
Meropenem—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.000395	CcSEcCtD
Meropenem—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000393	CcSEcCtD
Meropenem—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.000393	CcSEcCtD
Meropenem—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000392	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000391	0.000391	CcSEcCtD
Meropenem—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.000385	CcSEcCtD
Meropenem—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000383	CcSEcCtD
Meropenem—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000383	CcSEcCtD
Meropenem—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00038	0.00038	CcSEcCtD
Meropenem—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000377	CcSEcCtD
Meropenem—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000377	CcSEcCtD
Meropenem—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Meropenem—Infection—Epirubicin—peripheral nervous system neoplasm	0.000375	0.000375	CcSEcCtD
Meropenem—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.000373	CcSEcCtD
Meropenem—Shock—Epirubicin—peripheral nervous system neoplasm	0.000371	0.000371	CcSEcCtD
Meropenem—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00037	0.00037	CcSEcCtD
Meropenem—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000369	0.000369	CcSEcCtD
Meropenem—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000369	CcSEcCtD
Meropenem—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000368	CcSEcCtD
Meropenem—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000366	0.000366	CcSEcCtD
Meropenem—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000364	0.000364	CcSEcCtD
Meropenem—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000364	CcSEcCtD
Meropenem—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000363	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000361	CcSEcCtD
Meropenem—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000359	CcSEcCtD
Meropenem—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000352	CcSEcCtD
Meropenem—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000352	CcSEcCtD
Meropenem—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000349	CcSEcCtD
Meropenem—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000349	CcSEcCtD
Meropenem—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000347	CcSEcCtD
Meropenem—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000343	CcSEcCtD
Meropenem—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000342	CcSEcCtD
Meropenem—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000342	CcSEcCtD
Meropenem—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000341	CcSEcCtD
Meropenem—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.00034	CcSEcCtD
Meropenem—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.000339	CcSEcCtD
Meropenem—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000339	0.000339	CcSEcCtD
Meropenem—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000337	CcSEcCtD
Meropenem—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000336	0.000336	CcSEcCtD
Meropenem—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000335	CcSEcCtD
Meropenem—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.000333	CcSEcCtD
Meropenem—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000332	CcSEcCtD
Meropenem—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000328	CcSEcCtD
Meropenem—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000326	CcSEcCtD
Meropenem—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000325	0.000325	CcSEcCtD
Meropenem—Pain—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000322	CcSEcCtD
Meropenem—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000322	CcSEcCtD
Meropenem—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000316	CcSEcCtD
Meropenem—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000313	CcSEcCtD
Meropenem—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000311	CcSEcCtD
Meropenem—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000311	CcSEcCtD
Meropenem—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.00031	CcSEcCtD
Meropenem—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000308	CcSEcCtD
Meropenem—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000307	CcSEcCtD
Meropenem—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000303	CcSEcCtD
Meropenem—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000301	CcSEcCtD
Meropenem—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.0003	0.0003	CcSEcCtD
Meropenem—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000298	CcSEcCtD
Meropenem—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000298	CcSEcCtD
Meropenem—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000298	CcSEcCtD
Meropenem—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000298	CcSEcCtD
Meropenem—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000287	CcSEcCtD
Meropenem—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000285	CcSEcCtD
Meropenem—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000278	CcSEcCtD
Meropenem—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000277	CcSEcCtD
Meropenem—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Meropenem—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Meropenem—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000271	CcSEcCtD
Meropenem—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000267	CcSEcCtD
Meropenem—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000258	CcSEcCtD
Meropenem—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000257	CcSEcCtD
Meropenem—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.00025	CcSEcCtD
Meropenem—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000249	CcSEcCtD
Meropenem—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000247	CcSEcCtD
Meropenem—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00024	0.00024	CcSEcCtD
Meropenem—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000239	CcSEcCtD
Meropenem—Rash—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000238	CcSEcCtD
Meropenem—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000237	CcSEcCtD
Meropenem—Headache—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000236	CcSEcCtD
Meropenem—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000231	CcSEcCtD
Meropenem—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000224	CcSEcCtD
Meropenem—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000222	CcSEcCtD
Meropenem—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.00022	CcSEcCtD
Meropenem—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.00022	CcSEcCtD
Meropenem—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000219	CcSEcCtD
Meropenem—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000207	CcSEcCtD
